Buys
Open market- Shares
- Avg price
- Total value
Nicolas Leupin - Former Chief Medical Officer at NovoCure Ltd
Issuer-level insider activity
- Role
- Former Chief Medical Officer
- Issuer ticker
- NVCR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Nicolas Leupin in NovoCure Ltd
Sells
Open market- Shares
- -2,129
- Avg price
- $13.48
- Total value
- -$28,696
Net
Past year- Shares
- -2,129
- Share %
- -100%
- Total value
- -$28,696
Reported holdings for Nicolas Leupin in NovoCure Ltd
Form 4 holding
Former Chief Medical Officer
NovoCure Ltd
- Security class
- Stock Options (Right to buy)
- Shares / value
- 81,499
- Estimated value
- $1,482,467
- Report date
- 04 Mar 2025
- Price
- $18.19
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Former Chief Medical Officer
NovoCure Ltd
- Security class
- Ordinary Shares
- Shares / value
- 102,979
- Estimated value
- $1,370,176
- Report date
- 04 Mar 2026
- Price
- $13.31
- Ownership
- Direct
Transaction history for Nicolas Leupin in NovoCure Ltd
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.